Community Pharmacotherapy Program

The Community Pharmacotherapy Program (CPP) provides support, information, advice, training and resources for clients, pharmacists and medical practitioners involved in methadone and buprenorphine treatment for opioid dependence throughout WA.

CPP together with the Department of Health administer the clinical and regulatory controls which apply across the Program.

Training

The Community Pharmacotherapy Program also provides training and resources to medical practitioners and pharmacists who are, or wish to become, authorised to provide methadone and buprenorphine treatment. For more information visit this page.

Resources

• The WA Clinical Policies and Procedures for the Use of Methadone and Buprenorphine in the Treatment of Opioid Dependence
• Clinical Guidelines for Use of Depot Buprenorphine
• CPOP Information and support flyer

Forms for CPOP Prescribers

• Assessment of Acute Intoxication
• Application for Takeaway Doses
• Clinical Opiate Withdrawal Scale
• CPOP Formal Warning
• Interstate Overseas Travel Request
• Objective Opioid Withdrawal Scale
• Patient Application for Takeaway Doses
• Patient Consent for Depot Buprenorphine Treatment During Pregnancy and Breastfeeding
• Patient Consent to transfer to Buprenorphine from a Methadone dose greater than 40mg
• Patient Contract to Receive Opioid Substitution Treatment
• Pharmacotherapy Review Form
• Pharmacy Transfer Notification
• Subjective Opioid Withdrawal Scale
• Takeaway Dose Agreement
• Application to become a CPOP prescriber
• Methadone and Buprenorphine prescribing chart

Forms for CPOP Pharmacies

• Assessment of Acute Intoxication
• CPOP Formal Warning
• Pharmacy Client Agreement
• Pharmacy Dosing Errors - Recommended Action Plan
• Pharmacy Incident Report
• Pharmacy Ready Reference
• WA Health CPOP Forms for Pharmacists
• Pharmacist record - Depot Buprenorphine Administration
• Depot Buprenorphine Administration - Advice to Prescriber

Videos